In vitro studies of a prolactin antagonist, hPRL-G129R in human breast cancer cells.

International journal of oncology

Volumn 18, Issue 1, 2001, Pages 25-32

  Ramamoorthy, P ^a   Sticca, R ^a   Wagner, T E ^a   Chen, W Y ^a  

^a CLEMSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ARGININE; CASP3 PROTEIN, HUMAN; CASPASE; CASPASE 3; CISPLATIN; GLYCINE; PROLACTIN; TGFB1 PROTEIN, HUMAN; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

AMINO ACID SUBSTITUTION; ARTICLE; BREAST TUMOR; CELL CULTURE; CELL DIVISION; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; DRUG POTENTIATION; ENZYME ACTIVATION; FEMALE; GENETICS; HUMAN; METABOLISM; PATHOLOGY; POINT MUTATION;

AMINO ACID SUBSTITUTION; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; ARGININE; BREAST NEOPLASMS; CASPASE 3; CASPASES; CELL DIVISION; CISPLATIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; ENZYME ACTIVATION; FEMALE; GLYCINE; HUMANS; POINT MUTATION; PROLACTIN; TRANSFORMING GROWTH FACTOR ALPHA; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR CELLS, CULTURED;

EID: 0035219870     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.18.1.25     Document Type: Article

References (0)